In the pandemic’s first year, the work of ending the pandemic was confined to a relatively small domain: Labs and clinical trials
The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to Moderna, Inc., a biotechnology company based in Cambridge, Massachusetts, for its COVID-19 vaccine, which was co-developed with scientists at the National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID).
NIH observational study of coronavirus infection and multisystem inflammatory syndrome in children begins
An observational study has launched to evaluate the short- and long-term health outcomes of SARS-CoV-2 infection in children, including multisystem inflammatory syndrome in children (MIS-C), and to characterize the immunologic pathways associated with different disease presentations and outcomes.
African Development Bank Group Approves EUR400 million Lusophone Compact Guarantee program to boost private sector development
The Board of Directors of the African Development Bank (www.AfDB.org) Group on Wednesday approved the Lusophone Compact Guarantee Program (LCGP or the Compact), with a maximum risk exposure of up to EUR400 million.
The U.S. Food and Drug Administration granted emergency use authorization(link is external) (EUA) today for an innovative COVID-19 viral antigen test developed with support from the National Institutes of Health’s Rapid Acceleration of Diagnostics (RADx) Initiative.
We witness yet again
How angels walk among us – in various ways
holding our fragile selves together
nurturing hope, building hope!
The COVID-19 pandemic has highlighted the need for global solidarity and greater international cooperation, and must be turned into an opportunity for fundamental change, UN Secretary-General António Guterres said in a keynote address to the Nobel Peace Prize Forum on Friday.